[1] |
WANG Jiaxi, GUO Daihong, ZHANG Bo, Li Boyan, GUO Haili.
Automatic monitoring and risk factors of acute kidney injury in 116097 dosing cases of flurbiprofen axetil
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 201-205.
|
[2] |
HAO Gang, HAN Feng, ZHOU Gang, WU Xing, YAN Hao, LI Xuyang, HOU Hailing, NING Xiao, CUI Li.
Methodological study of adenosylcobalamin bacterial endotoxin examination for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1351-1356.
|
[3] |
LI Qianqian, XIA Yan, HOU Tiantian, WANG Chao, SHI Xixi, MA Xuemei, LIU Ziyang, ZHANG Yingli, WU Xiaobing, WANG Sanlong, LIU Guoqing, GENG Xingchao.
Nonclinical evaluation of safety of gene therapy drug AAV5 lipoprotein lipase variant (GC304) in the nervous system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 34-39.
|
[4] |
ZHONG Lumiao, DU Juan, DENG Hua, WANG Yafeng, QIU Ping, ZENG Linggui.
Thoughts on design and quality management of active safety surveillance research of traditional Chinese medicine injections initiated by Marketing Authorization Holder
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 994-998.
|
[5] |
HUANG Ying, HOU Tiantian, QIN Chao, HUO Yan, WANG Sanlong, WEN Hairuo, GENG Xingchao.
Nonclinical research on CAR-T cell products: main concerns and key issues
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 813-816.
|
[6] |
HUANG Ying, WEN Hairuo, HOU Tiantian, HUO Yan, WANG Sanlong, GENG Xingchao.
Cloning ability of CAR-T cells in soft agar and tumorigenicity in vitro
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 836-838.
|
[7] |
ZHANG Dousheng, WANG Chen, XU Mingzhe.
Rapid evaluation of potential neurotoxicity of levornidazole for injection and its main impurities based on computational models and database technology
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 712-716.
|
[8] |
FU Lu, PENG Huasheng, YUAN Yuan, JIN Yan.
Herbal textual research on toxicity of Zanthoxylum bungeanum
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 369-371.
|
[9] |
YANG Jingfan, XU Lu, CHEN Suiqing.
Textual research of the toxic herb Kansui Radix
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 372-375.
|
[10] |
GENG Hongjiao, WANG Ya, ZHANG Yili, XIE Yanming, CHEN Renbo, GAI Guozhong, ZHANG Wenli.
Real-World Study on Use of Maixuekang Capsules Combined with Western Medicines in Treating Coronary Heart Disease
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 701-704.
|
[11] |
ZHANG Dan, LYU Jintao, ZHANG Bing, LIN Zhijian, WU Huanzhang, ZHANG Xiaomeng.
Construction and Application of Four-Dimensional and Chained Research Platform for Pharmacovigilance of Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 416-421.
|
[12] |
SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng.
Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.
|
[13] |
YANG Ming, LUO Hui, LIU Jianping.
Progress in Methods of Research into Clinical Interactions between Traditional Chinese Medicine and Chemical Medicine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1029-1033.
|
[14] |
CHENG Jinlian, OUYANG Huitian, JIN Hongtao, ZHU Xueqi, XIAO Shuang, LEI Xiang, GAO Chunsheng, LIU Qingquan.
Thoughts and Suggestions on Safety Evaluation of Combined use of Traditional Chinese Medicine in Clinical Research
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 4-10.
|
[15] |
ZHU Xueyan.
Research and Application Progress of Two-dimentional Liquid Chromatography on Quality Control for Traditional Chinese Herbal Medicines
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 643-646.
|